The IT industry may have been heavily impacted by AI with widespread layoffs in major companies. But now, AI companies, OpenAI and Anthropic, have created a new IT role called Forward Deployment ...

Invincible VS, the superhero 3v3 tag fighting game set in the Invincible universe, is coming to PC, Xbox, and PlayStation 5 on April 30. Developer Quarter Up has now confirmed the exact global release ...

The Orlando Magic secured the final playoff spot in the Eastern Conference, dominating the Charlotte Hornets 121-90. Paolo Banchero scored 25 points en route to victory, as the Magic return to the NBA ...

Rookie Kon Knueppel was awful in his postseason debut but will find other ways to help the Charlotte Hornets when they visit the Orlando Magic in the Play-In finale. Jason Logan is betting on Knueppel ...

The Philadelphia 76ers will be moving on. With their 109-97 takedown Wednesday, April 15 over the Orlando Magic in the Play-In Tournament, the Sixers have secured the No. 7 seed in the NBA Playoffs ...

The No. 10 seed Golden State Warriors will play the No. 7 seed Phoenix Suns at Mortgage Matchup Center on Friday, April 17, in the SoFi NBA Play-In Tournament following Wednesday’s 126-121 win over ...

The NBA Play-In Tournament continued Wednesday with the 76ers clinching a playoff berth and the Warriors extending their season. Behind 31 points from Tyrese Maxey, Philadelphia advanced to the ...

A beloved burger chain is continuing its steady expansion with four new stores across four states. The four new locations come after the chain announced its plans for growth in late 2025 and opened ...

Iowa basketball is back in the Sweet 16 of the NCAA Tournament for the first time since 1999. On Friday, the 9-seed Hawkeyes took down 1-seed Florida in the second round, setting up a date with 4-seed ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. We made it, friends. The craziest and most chaotic sports tournament of ...

Apixaban and rivaroxaban are the oral anticoagulants most frequently used to treat acute venous thromboembolism. However, uncertainty remains about the difference in bleeding risk between the two ...